Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the FDA means a product can stay on the market even after a health emergency ...

Many doctors recommend routine follow-up tests for cancer patients after they’ve completed a course of treatment, with the ...

After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.

The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...

Novavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...

Former National Institutes of Health Director Dr. Francis Collins, who abruptly left his NIH research lab in February, fears ...

Washington has tens of thousands of farms producing billions of dollars worth of meat, produce and dairy products.

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

The Washington Post/ABC/Ipsos and the AP/NORC poll out in the last couple of days even show him with a 39% approval rating ...

The vaccine was approved by the FDA for people aged 12 and over in August ... as they are more at risk for serious complications from COVID-19 infections. The stroke signal has not been identified ...

The announcement came as Gilead recorded a 2% decline in fourth quarter sales, mainly resulting from a slump in demand for its COVID-19 therapy ... an approval from the FDA for Veklury as an ...